In 1925, the pioneering German chemists Ida Tackeand Walter Noddack announced the discovery of element 75 and named this new element rhenium in honor of the river Rhine (Latin Rhenus) [1] . The couple would later marry and continue their influential work as a team for the remainder of their professional careers. Remarkably, the pair also made valuable contributions to the discovery of technetium, which along with rhenium were the last two missing elements of the main periodic Tc therefore represent an ideal theranostic radionuclide pair. It now seems particularly fitting that the current partnering of these two radionuclides in a theranostic model stems from the discoveries of two partnering chemists almost a century ago.
In 1925, the pioneering German chemists Ida Tackeand Walter Noddack announced the discovery of element 75 and named this new element rhenium in honor of the river Rhine (Latin Rhenus) [1] . The couple would later marry and continue their influential work as a team for the remainder of their professional careers. Remarkably, the pair also made valuable contributions to the discovery of technetium, which along with rhenium were the last two missing elements of the main periodic table at the time [1] . Both these elements belong to group 7 of the periodic table and thus share similar chemistry. Being suitable for therapeutic and diagnostic purposes respectively, 188 Re and 99m Tc therefore represent an ideal theranostic radionuclide pair. It now seems particularly fitting that the current partnering of these two radionuclides in a theranostic model stems from the discoveries of two partnering chemists almost a century ago.
188
Re(T 1/2 17 hours) has excellent physical properties as a therapeutic radionuclide. The high energy β emission(E β max 2.12 MeV)has a maximum range of 10.4 mm and the accompanying 155 keV energy gamma emission (15% abundance) facilitates imaging for biodistribution anddosimetry assessment [2] . In addition, the on-demand availability of Re generator can potentially allow daily clinical access in a cost effective manner per unit dose [3] . These attractive properties of 188 Re have been utilized in several clinical applications over the last three decades including intra-arterial therapy of hepatocellular carcinoma, treatment of metastatic bone pain and radiosynoviorthesis [4] [5] [6] . Re and 99m Tc is set for a revival!
